For use of specialist in hospital/institution set-up only

ANNOUNCEMENT ON REMDESIVIR

DESREMTM (Remdesivir for Injection 100 mg/vial) is approved by DCGI for treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalised with severe disease.

Press Release

Mylan gets DCGI nod for remdesivir in India, to Launch at Rs. 4,800 per vial
Mylan launches generic version of Remdesivir in India for Covid-19 patients

Data on File. Remdesivir for Injection 100 mg vial approval letter. Mylan Laboratories Limited. 2020.

Press Release


Economic Times

Mylan gets DCGI nod for remdesivir in India, to Launch at Rs. 4,800 per vial


Times of India

Mylan launches generic version of Remdesivir in India for Covid-19 patients

content